Chronic myelomonocytic leukemia diagnosis and management von Chan, Onyee, Renneville, Aline, Padron, Eric

Volltext

Increasing recognition and emerging therapies argue for dedicated clinical trials in chronic myelomonocytic leukemia von Renneville, Aline, Patnaik, Mrinal M., Chan, Onyee, Padron, Eric, Solary, Eric

Volltext

Cold but not sympathomimetics activates human brown adipose tissue in vivo von Cypess, Aaron M, Chen, Yih-Chieh, Sze, Cathy, Wang, Ke, English, Jeffrey, Chan, Onyee, Holman, Ashley R, Tal, Ilan, Palmer, Matthew R, Kolodny, Gerald M, Kahn, C. Ronald

Volltext

Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemia von Pavlovsky, Carolina, Chan, Onyee, Talati, Chetasi, Pinilla-Ibarz, Javier

Volltext

Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia von Chan, Onyee, Talati, Chetasi, Isenalumhe, Leidy, Shams, Samantha, Nodzon, Lisa, Fradley, Michael, Sweet, Kendra, Pinilla-Ibarz, Javier

Volltext

IDH mutations are enriched in myelodysplastic syndrome patients with severe neutropenia and can be a potential for targeted therapy von Komrokji, Rami, Al Ali, Najla, Chan, Onyee, Sweet, Kendra, Kuykendall, Andrew, Lancet, Jeffrey, Padron, Eric, Sallman, David A

Volltext

Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia von Jain, Akriti G, Ball, Somedeb, Aguirre, Luis, Al Ali, Najla, Kaldas, David, Tinsley-Vance, Sara, Kuykendall, Andrew, Chan, Onyee, Sweet, Kendra, Lancet, Jeffrey E, Padron, Eric, Sallman, David A, Komrokji, Rami

Volltext

PTPN11 mutations are associated with poor outcomes across myeloid malignancies von Swoboda, David M., Ali, Najla Al, Chan, Onyee, Padron, Eric, Kuykendall, Andrew T., Song, Jinming, Hussaini, Mohammad, Talati, Chetasi, Sweet, Kendra, Lancet, Jeffrey E., Sallman, David A., Komrokji, Rami S.

Volltext

Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts von Swoboda, David M., Kanagal-Shamanna, Rashmi, Brunner, Andrew M., Cluzeau, Thomas, Chan, Onyee, Al Ali, Najla, Montalban-Bravo, Guillermo, Gesiotto, Quinto J., Gavralidis, Alexander, Hunter, Anthony M., Lee, Jung-Hoon, Kuykendall, Andrew T., Talati, Chetasi, Sweet, Kendra L., Lancet, Jeffrey E., Padron, Eric, Hussaini, Mohammad, Song, Jinming, Garcia-Manero, Guillermo, Komrokji, Rami S., Sallman, David A.

Volltext

Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome von Komrokji, Rami S., Singh, Avani M., Ali, Najla Al, Chan, Onyee, Padron, Eric, Sweet, Kendra, Kuykendall, Andrew, Lancet, Jeffrey E., Sallman, David A.

Volltext

Distinct clinico-genomic factors drive outcomes in patients with myelofibrosis and disease-related anemia von Ball, Somedeb, Al Ali, Najla H., Jain, Akriti G., Aguirre, Luis E., Yun, Seongseok, Chan, Onyee, Xie, Zhuoer, Sallman, David A., Lancet, Jeffrey, Padron, Eric, Komrokji, Rami S., Kuykendall, Andrew T.

Volltext

P727: REFINING RISK STRATIFICATION IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML): A COMPREHENSIVE ASSESSMENT OF THE IPSS‐M AND OTHER MOLECULARLY INTEGRATED PROGNOSTIC MODELS von Aguirre, Luis E., Jain, Akriti, Ball, Somedeb, Al Ali, Najla, Sallman, David, Kuykendall, Andrew, Chan, Onyee, Xie, Zhuoer, Walker, Alison, Sweet, Kendra, Lancet, Jeffrey, Padron, Eric, S. Komrokji, Rami

Volltext

PB1847: A PHASE 1 STUDY TO INVESTIGATE CLN‐049, A FLT3/CD3 BISPECIFIC T CELL ENGAGER, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML) OR MYELODYSPLASTIC SYN... von Abdul‐Hay, Maher, Dinardo, Courtney, Chan, Onyee, Narayan, Rupa, Issa, Ghayas, Michaelson, Jennifer, Baeuerle, Patrick, Meetze, Kristan, Janik, John, Shapiro, Irina, Inumerable, Judy, Jones, Jeffery, Sallman, David

Volltext

Coccidioidomycosis with Pericardial Involvement: Case Report and Literature Review von Chan, Onyee, MD, Low, See Wei, MD, Urcis, Rafael, MD, Mahmoud, Naser, MD, Yumul, Ily Kristine T., MD, Po, John Leander Z., MD, Zangeneh, Tirdad T., DO

Volltext

Moving towards a uniform risk stratification system in CMML - How far are we? von Chan, Onyee, Padron, Eric

Volltext

Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report von Sokolova, Alexandra, Chan, Onyee, Ullah, Waqas, Hamdani, Auon Abbas, Anwer, Faiz

Volltext

S170: MYELODYSPLASTIC NEOPLASMS (MDS) CLASSIFICATION FROM WHO 2017 TO WHO 2022 AND ICC 2022): AN EXPANDED ANALYSIS OF 7017 PATIENTS ON BEHALF OF THE INTERNATIONAL CONSORTIUM FOR MD... von Komrokji, Rami S., Ball, Somdeb, Maggioni, Giulia, Travaglino, Erica, Al Ali, Najla, Fenaux, Pierre, Platzbecker, Uwe, Santini, Valeria, Díez Campelo, María, Haferlach, Torsten, Singh, Avani, Jain, Akriti, Aguirre, Luis E., Tinsley, Sara, Schwabkey, Zaker, Chan, Onyee, Xie, Zhuoer, Brunner, Andrew, Kuykendall, Andrew, Bennett, John, Buckstein, Rena, Bejar, Rafael, Bewersdorf, Jan, Carraway, Hetty, Dezern, Amy, Griffiths, Elizabeth A., Halene, Stephanie, Hasserjian, Robert Paul, Loghavi, Sanam, Odenike, Olatoyosi, Patnaik, Mrinal, Roboz, Gail, Stahl, Maximillian, Sekeres, Mikkael, Steensma, David, Savona, Michael Robert, Taylor, Justin, Xu, Mina, Sweet, Kendra, Lancet, Jeffrey, List, Alan, Padron, Eric, Sallman, David, Zeidan, Amer M., Della Porta, Matteo Giovanni

Volltext

Hodgkin Lymphoma Mimicking Osteomyelitis von Majeed, Aneela, Chan, Onyee, Okolo, Onyemaechi, Shponka, Volodymyr, Georgescu, Anca, Persky, Daniel

Volltext

Luspatercept in the treatment of lower-risk myelodysplastic syndromes von Chan, Onyee, Komrokji, Rami S.

Volltext

Phase 1b/2 Study Evaluating the Safety and Efficacy of Canakinumab with Darbepoetin Alfa in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Who Have Failed Erythropoietin... von Sallman, David A, Hunter, Anthony M, Xie, Zhuoer, McLemore, Amy, Kuykendall, Andrew T., Nardelli, Lisa Ann, Chan, Onyee, Padron, Eric, Lancet, Jeffrey, Komrokji, Rami S.

Volltext